Peer-influenced content. Sources you trust. No registration required. This is HCN.
Healthline
Magnesium glycinate supplementation may offer benefits for various health conditions, including anxiety, bone health, blood sugar management, and premenstrual syndrome symptoms.
Cardiology October 10th 2024
Journal of Neurology, Neurosurgery & Psychiatry
CGRP inhibitors have shown promise in reducing migraine days and improving quality of life, but their wide-ranging effects throughout the body warrant careful consideration and long-term monitoring.
Clinical Pharmacology August 27th 2024
Practical Neurology
Noninvasive neuromodulation devices offer effective headache management options with minimal adverse events, providing both acute and preventive treatment capabilities. Understanding their mechanisms and practical uses is crucial for optimizing patient care.
Neurology June 24th 2024
The New England Journal of Medicine
A sudden, severe headache in a 64-year-old woman led to a diagnosis of Reversible Cerebral Vasoconstriction Syndrome (RCVS) with Takotsubo Cardiomyopathy. Early imaging and targeted management were key to successful outcomes.
Emergency Medicine June 18th 2024
MDLinx
Physicians managing migraine patients should consider the complex relationship between migraines and sexual activity, as emerging research suggests potential therapeutic benefits alongside risks of exacerbation.
Internal Medicine April 9th 2024
The AHS’s new consensus underscores the pivotal role of CGRP-targeting therapies in migraine prevention, marking a key advancement in patient care. These treatments offer a focused approach, approved for both episodic and chronic migraine, setting a new standard in therapeutic strategies.
Neurology March 19th 2024